Overview of This Study:
This study involved four major activities in estimating the current size of the primary cells market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
The growth of primary cell market is mainly driven by factors such as increasing cancer research, advantages of primary human cells over cell lines, increasing demand for monoclonal antibodies, rapid growth of biotechnology and biopharmaceutical industries, and increasing interest in personalized medicine is driven by It is driven by biomedical research using primary cells in 3D culture and is expected to provide a wide range of growth opportunities for the players in the market.
Recent Developments in Primary Cells Market
- In May 2020, BioIVT (US) introduced high-purity Kupffer cells to its portfolio of human primary hepatic cells to support liver disease drug discovery and development.
- In January 2020, Charles River Laboratories acquired HemaCare Corporation. This acquisition will aid in expanding Charles River’s scientific capabilities in the high-growth cell therapy sector.
- In September 2018, Sekisui XenoTech, LLC. (US) added monkey and rodent hepatocytes to its patented CryostaX product line.
Driver: Increasing cancer research
Cancer, which has become the leading cause of death globally, accounted for 9.6 million deaths in 2018. The growth in the prevalence of this disease has resulted in a need to conduct extensive research for diagnosis and treatment; primary cells form an important part of this research. These cells are ideal models for cancer biomarker discovery and drug screening.
Global Key Market Players
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US)
Different Growth Strategies Adopted by Them:
Market Competitive Analysis:
Top 10 players in this industry profiled in the report include. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.
Thermo Fisher Scientific accounted for the largest share of the primary cells market in 2019. The company maintains its leading position in the primary cells market due to its well-established product portfolio. The company adopted partnerships and expansions as key strategies to strengthen its position as well as expand its product portfolio.
Merck KGaA accounted for the second-largest share of the primary cells market. The company has a strong foothold in this market with its extensive range of primary cell products. To maintain its leading position in the primary cells market, the company focuses on organic growth strategies such as expansions.
Lonza (Switzerland) is engaged in providing chemical and biotechnology ingredients and custom manufacturing services to the pharmaceutical, healthcare, and life science industries. The company operates through two divisions, namely, Specialty Ingredients and Pharma, Biotech & Nutrition.
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
Major Revenue Growth Expectations:
The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%.